Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2015 16:05 ET | Source: Fibrocell Science Inc.

Fibrocell to Present at Jefferies 2015 Global Healthcare Conference

EXTON, Pa., May 26, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (Nasdaq:FCSC), an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious...
May 12, 2015 16:05 ET | Source: Fibrocell Science Inc.

Fibrocell Receives Rare Pediatric Disease Designation From FDA for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

EXTON, Pa., May 12, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (Nasdaq:FCSC), an autologous cell and gene therapy company primarily focused on developing first-in-class treatments for rare and...
May 08, 2015 08:05 ET | Source: Fibrocell Science Inc.

Fibrocell Science Reports First Quarter 2015 Financial and Operating Results

- Continued Progress Advancing Pipeline of Innovative, Autologous Cell and Gene Therapies for Rare Skin and Connective Tissue Diseases - - Company to Host Conference Call and Webcast, Today at...
May 01, 2015 08:30 ET | Source: Fibrocell Science Inc.

Fibrocell Science to Report First Quarter 2015 Financial and Operating Results, and Host Conference Call and Webcast on Friday, May 8, 2015

EXTON, Pa., May 1, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq:FCSC), an autologous cell and gene therapy company primarily focused on developing first-in-class treatments for rare and...
April 17, 2015 08:05 ET | Source: Fibrocell Science Inc.

Fibrocell Science to Present at World Orphan Drug Congress USA 2015

EXTON, Pa., April 17, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (Nasdaq:FCSC), an autologous cell and gene therapy company primarily focused on developing first-in-class treatments for rare...
March 18, 2015 16:05 ET | Source: Fibrocell Science Inc.

Fibrocell Science Appoints Keith A. Goldan, Senior Vice President and Chief Financial Officer

EXTON, Pa., March 18, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious...
March 13, 2015 08:10 ET | Source: Fibrocell Science Inc.

Fibrocell Science Reports Fourth Quarter and Full Year 2014 Financial and Operating Results

- Significant progress advancing gene therapy candidate for recessive dystrophic epidermolysis bullosa (RDEB), a devastating and progressive orphan skin disease - - Phase II clinical trial...
March 05, 2015 16:05 ET | Source: Fibrocell Science Inc.

Fibrocell Science to Report Fourth Quarter 2014 and Full Year 2014 Financial and Operating Results, and Host Conference Call and Webcast on March 13, 2015

EXTON, Pa., March 5, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and...
January 07, 2015 08:05 ET | Source: Fibrocell Science Inc.

Fibrocell Science to Present at Biotech Showcase 2015 Conference

EXTON, Pa., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (Nasdaq:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and...
November 18, 2014 08:00 ET | Source: Fibrocell Science Inc.

Fibrocell Science Announces IND Allowed to Proceed to Develop New Treatment for Wounded Warrior Amputees to Prevent Stump Skin Diseases

EXTON, Pa., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (Nasdaq:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and...